Advertisement

Related Videos

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

Varsha Gandhi, PhD, on Ibrutinib

Focus on Optimized Dosing of Ibrutinib Panel Discussion

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

David A. Hyman, MD, JD, on Inclusive Shared Savings

Advertisement

Advertisement




Apr
15
Today In Oncology
Large Language Models May Generate Concise, Coherent Pathology Summaries, Reducing Physician Burden
PSMA PET-CT Scan Reduces Need for Prostate Cancer Biopsies
Surgery Still Safe Beneficial For Many Octogenarian Patients With NSCLC
Prompting Strategies Improve Symptom Monitoring in Childhood Cancer Survivors
NCCN Names New Chief Scientific Officer
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo